Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy: Quality of life in high-risk prostate cancer patients

Asian Journal of Andrology

Volumn 8, Issue 5, 2006, Pages 629-636

  Kang, Seok Ho ^a   Kim, Jin Wook ^a   Bae, Jae Hyun ^a   Park, Hong Seok ^a   Moon, Du Geon ^a   Yoon, Duck Ki ^a   Cheon, Jun ^a   Kim, Je Jong ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Cryosurgery; EORTCQLQ C30; Hormone antagonist; Prostate cancer; Prostatic neoplasm; Quality of life; Targeted cryosurgical ablation of the prostate

Indexed keywords

ANTIANDROGEN; GONADORELIN DERIVATIVE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLADDER IRRITATION; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CRYOSURGERY; CYSTOSCOPY; DEFECATION DISORDER; DISEASE ASSOCIATION; EJACULATION DISORDER; ERECTILE DYSFUNCTION; FOLLOW UP; GLEASON SCORE; GYNECOMASTIA; HEALTH STATUS; HIGH RISK PATIENT; HOT FLUSH; HUMAN; LONG TERM CARE; MALE; MINIMALLY INVASIVE SURGERY; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS PAIN SYNDROME; PROSTATE BIOPSY; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RANK SUM TEST; SCROTAL SWELLING; SEXUAL DYSFUNCTION; STUDENT T TEST; SYMPTOMATOLOGY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINE RETENTION;

AGED; AGED, 80 AND OVER; CRYOSURGERY; EJACULATION; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; KOREA; LIBIDO; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33747619193     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1111/j.1745-7262.2006.00176.x     Document Type: Article

References (20)

1. McCammon KA, Kolm P, Main B, Schellhammer PF. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology 1999; 54: 509-16.
2. Flocks RH, Nelson CM, Boatman DL. Perineal cryosurgery for prostatic carcinoma. J Urol 1972; 108: 933-5.
3. Donnelly BJ, Saliken JC, Ernst DS, Ali-Ridha N, Brasher PM, Robinson JW, et al. Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology 2002; 60: 645-9.
4. Long JP, Bahn D, Lee F, Shinohara K, Chinn DO, Macaluso, JN Jr. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 2001; 57: 518-23.
5. Han KR, Cohen JK, Miller RJ, Pantuck AJ, Freitas DG, Cuevas CA, et al. Treatment of organ confined prostate cancer with third generation cryosurgery: Preliminary multicenter experience. J Urol 2003; 170: 1126-30.
6. Prepelica KL, Okeke Z, Murphy A, Katz AE. Cryosurgical ablation of the prostate: High risk patient outcomes. Cancer 2005; 103: 1625-30.
7. Robinson JW, Donnelly BJ, Saliken JC, Weber BA, Ernst S, Rewcastle JC. Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery. Urology 2002; 60: 12-8.
8. Perrotte P, Litwin MS, McGuire EJ, Scott SM, Von Eschenbach, AC, Pisters LL. Quality of life after salvage cryotherapy: The impact of treatment parameters. J Urol 1999; 162: 398-402.
9. Anastasiadis AG, Sachdev R, Salomon L, Ghafar MA, Stisser BC, Shabsigh R, et al. Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer. J Cancer Res Clin Oncol 2003; 129: 676-82.
10. Borghede G, Sullivan M. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res 1996; 5: 212-22.
11. Fransson P, Damber JE, Tomic R, Modig H, Nyberg G, Widmark A. Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma. Cancer 2001; 92: 3111-9.
12. Sharifi N, Gulley JL, Dahut WL. Androgen deprivation therapy for prostate cancer. JAMA 2005; 294: 238-44.
13. Bolla M, Gonzalez D, Warde P, Dubois JB, Mirimanoff RO, Storme G, et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 1997; 337: 295-300.
14. Pilepich MV, Caplan R, Byhardt RW, Lawton CA, Gallagher MJ, Mesic JB, et al. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of Radiation Therapy Oncology Group Protocol 85-31. J Clin Oncol 1997; 15: 1013-21.
15. Baust JG, Gage AA. The molecular basis of cryosurgery. BJU Int 2005; 95: 1187-91.
16. Fayers P, Bottomley A; EORTC Quality of Life Group; Quality of Life Unit. Quality of life research within the EORTC-The EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer 2002; 38 (Suppl 4): S125-33.
17. Shinohara K, Rhee B, Presti JC Jr, Carroll PR. Cryosurgical ablation of prostate cancer: Patterns of cancer recurrence. J Urol 1997; 158: 2206-9.
18. Robinson JW, Moritz S, Fung T. Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 2002; 54: 1063-8.
19. Litwin MS. Quality of life following definitive therapy for localized prostate cancer: Potential impact of multiple therapies. Curr Opin Urol 2003; 13: 153-6.
20. Pilepich MV, Krall J, George FW, Asbell SO, Plenk HD, Johnson RJ, et al. Treatment-related morbidity in phase III RTOG studies of extended-field irradiation for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1984; 10: 1861-7.